Emerging Players in the Taiwan Risperidone Market | Top Companies & Insights 2026

Taiwan Risperidone Market Overview

According to 6Wresearch, the Taiwan risperidone market is growing steadily, owing to the rising prevalence of mental health disorders, especially schizophrenia and bipolar disorder, and the growing social awareness of psychiatric treatments. Risperidone is recognized as a second-generation atypical neuroleptic that balances dopamine and serotonin levels in the brain. The development of the market is being contributed through increased use of generic alternatives and hospital-based psychiatric care. The healthcare infrastructure is developing further, with a growing number of mental health facilities and private clinics contributing to the expansion of the pharmaceutical supply chain for antipsychotic drugs.

Competitive Landscape

The competitive landscape of the Taiwan Risperidone Industry includes local manufacturers and international pharmaceutical giants offering a variety of dosage forms, including orally disintegrating tablets, and extended-release injections. The industry leaders are actively engaged in ensuring the availability of cost-effective generics and innovative delivery systems to develop patient adherence.

Below is a list of leading players operating in the Taiwan Risperidone Market:

1. Janssen (Johnson & Johnson) Taiwan Ltd.

Janssen is the original innovator of Risperdal and remains a dominant force with its advanced delivery systems.

2. Standard Chem. & Pharm. Co., Ltd.

Standard is a leading domestic manufacturer providing high-quality, affordable generic risperidone to the Taiwan mass market.

3. TTY Biopharm Company Limited

TTY Biopharm is a leader in the neuropsychiatry segment, providing widely prescribed risperidone brands for schizophrenia management.

4. Yung Shin Pharmaceutical Ind. Co., Ltd.

Yung Shin focuses on specialized therapies, maintaining a strong presence in the central nervous system market with its psychiatric portfolio.

5. Sandoz (Novartis Healthcare Taiwan)

Novartis provides bioequivalent generic risperidone, leveraging global research to ensure high standards of efficacy and safety.

6. Lotus Pharmaceutical Co., Ltd.

Lotus Pharma is a key international player known for its extensive range of CNS medications, offering cost-effective psychiatric solutions.

7. Synmosa Biopharma Corporation

Synmosa maintains a strong presence through its commitment to accessible healthcare and its portfolio of essential central nervous system treatments.

8. Orient EuroPharma Co., Ltd. (OEP)

OEP is a key supplier and distributor of antipsychotic drugs, known for its excellence in psychiatric formulations and market reach.

9. China Chemical & Pharmaceutical Co., Ltd. (CCPC)

CCPC provides a diverse range of pharmaceutical solutions and specialty products that support hospital-based psychiatric care.

10. Viatris Taiwan (formerly Mylan/Pfizer Upjohn)

Viatris is a specialized player in the CNS therapeutic area, focusing on high-quality antipsychotic medications and patient-centric care.